A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse modelsPär Larsson, Malin Flodström‐Tullberg, Olli H. Laitinen et al.|Diabetologia|2014Cited by 43
Genetic Adaptation of Coxsackievirus B1 during Persistent Infection in Pancreatic CellsAnni Honkimaa, Heikki Hyöty|Microorganisms|2020Cited by 13
Early-life immunological and microbial differences between East African and North European childrenNoora Nurminen, Heikki Hyöty|Communications Medicine|2026Cited by 0